Leerink Partners upgraded Achillion Pharmaceuticals Inc. (Nasdaq: ACHN) from a Market Perform rating to an Outperform rating lifting the stock price 63 cents to close at $4.41.
Achillion Pharmaceuticals upgraded
May 18, 2017 at 18:48 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|